cdmo.directory
← Compare landing

AXOlabs vs Bachem

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/axolabs/bachem

CategoryAXOlabsBachem
Listed sitebothcdmo
SummaryIntegrated CRO and CDMO specializing in nucleic acid therapeutics (ASOs, siRNA, sgRNA, aptamers) from lead identification through GMP manufacturing, with dual-site facilities in Petaluma, USA and Berlin, Germany.Global leader in peptide and oligonucleotide development and manufacturing, offering GMP-compliant clinical and commercial supply from early research through commercial scale.
Services
  • Bioinformatics & Data Science
  • High-Throughput Screening
  • Target Identification & Validation
  • Discovery Research
  • GLP Toxicology
  • In Vivo PK / PD Studies
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • In Vitro Pharmacology
  • Oligonucleotide Manufacturing
  • Process Development
  • CMC Analytical Development
  • Technology Transfer
  • Process Development
  • Formulation Development
  • CMC Regulatory Submission Support
  • Quality Control Testing
  • Technology Transfer
  • Peptide Manufacturing
  • Oligonucleotide Manufacturing
  • API Synthesis & Manufacturing
  • CMC Analytical Development
Modalities
  • Oligonucleotide
  • Peptide
  • Oligonucleotide
IndicationsData not yet provided.Data not yet provided.
Locations
  • Petaluma, Petaluma, California, USA
  • Berlin, Berlin, Berlin, Germany
  • Kulmbach, Kulmbach, Bavaria, Germany
  • Headquarters, Bubendorf, Switzerland
  • Vionnaz, Vionnaz, Switzerland
  • Sisslerfeld, Sisslerfeld, Switzerland
  • Torrance, Torrance, California, United States
  • Vista, Vista, California, United States
  • St. Helens, St. Helens, United Kingdom
  • Americas, Torrance, California, USA
  • Asia Pacific, Tokyo, Tokyo, Japan
Certifications
  • GLP · Identifier: Statement of GLP Compliance (06 Dec 2024)
  • GMP · Identifier: Certificate of GMP Compliance (Regierung von Oberfranken, 14 Oct 2024)
  • Swissmedic · Identifier: Betriebsbewilligung Arzneimittel - Bubendorf
  • Swissmedic · Identifier: Betriebsbewilligung TpP/GT/GVO - Bubendorf Oligonukleotide
  • FDA · Identifier: FDA Manufacturing License - Torrance
  • FDA · Identifier: FDA Manufacturing License - Vista
  • Swissmedic · Identifier: Manufacturing license - Vionnaz
  • PMDA · Identifier: Japanese Accreditation as Foreign Manufacturer - Bachem AG
  • PMDA · Identifier: Japanese Accreditation as Foreign Manufacturer - Bachem Americas Inc.
  • PMDA · Identifier: Japanese Accreditation as Foreign Manufacturer - Bachem SA, Succursale de Vionnaz
  • ISO · Identifier: ISO 13485 - Bachem (UK) Ltd.
  • EDQM · Identifier: CEP - Desmopressin Acetate Ph. Eur.
  • EDQM · Identifier: CEP - Gonadorelin Acetate Ph. Eur.
  • EDQM · Identifier: CEP - Goserelin Acetate Ph. Eur.
  • EDQM · Identifier: CEP - Leuprolide Acetate Ph. Eur.
  • EDQM · Identifier: CEP - Octreotide Ph. Eur.
  • EDQM · Identifier: CEP - Somatostatin Ph. Eur.
  • EDQM · Identifier: CEP - Carbidopa Ph. Eur.
  • EDQM · Identifier: CEP - Etomidate Ph. Eur.
  • EDQM · Identifier: CEP - Propofol Ph. Eur.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.